New options in the management of intractable ALK(+) metastatic non-small-cell lung cancer


Non-small-cell lung cancer (NSCLC) is a heterogeneous disease and a challenging malignancy to treat, as many patients have advanced disease at the time of diagnosis. Recent advances have led to the identification of molecularly defined subtypes of NSCLC, namely for patients with adenocarcinoma histology. The most recently identified molecular target is the… (More)
DOI: 10.2147/LCTT.S50414


3 Figures and Tables